Feb 2026 $36 M No. 9 $10 to $50 million 9
Innovative Pulmonary Solutions, Inc.: Raise no. 9, Feb 2026 × Investors in this round 9 investors had bought by the notice of Mar 4, 2026: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $36 M of $64 M offered; $28 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Conversion of SAFEs; Conversion of debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis W. Wahr · Executive Officer, Director Edward J. Morgan · Director Geoffrey J. Duyk · Director Timothy W. Herbert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Excludes standard compensation for officers and directors.”Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Mar 4, 2026. Read the notice at the SEC .
equity SEC Nov 2023 $15 M No. 8 $10 to $50 million 39
Innovative Pulmonary Solutions, Inc.: Raise no. 8, Nov 2023 × Investors in this round 39 investors had bought by the notice of Dec 1, 2023: 39 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $17 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis W. Wahr · Executive Officer, Director Tom A. Griffin · Executive Officer David A. Van Meter · Director Henry A. Plain · Director Jacques A. Essinger · Director Jonathan A. Root · Director Michael A, Carusi · Director Timothy A. Herbert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Excludes standard compensation for officers and directors.”Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Dec 1, 2023. Read the notice at the SEC .
equity SEC Jul 2020 $31 M No. 7 $10 to $50 million 49
Innovative Pulmonary Solutions, Inc.: Raise no. 7, Jul 2020 × Investors in this round 49 investors had bought by the notice of Jan 19, 2022: 49 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $31 M of $68 M offered; $37 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis W. Wahr · Executive Officer, Director Gary A. Rieschel · Director Henry A. Plain · Director Jonathan A. Root · Director Michael A. Carusi · Director Robert A. O'Holla · Director Tim A. Herbert · Director Yoh-Chie A. Lu · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Excludes standard compensation for officers and directors.”Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Jan 19, 2022 (2 amendments). Read the notice at the SEC .
equity SEC Feb 2019 $25 M No. 6 $10 to $50 million 20
Innovative Pulmonary Solutions, Inc.: Raise no. 6, Feb 2019 × Investors in this round 20 investors had bought by the notice of Feb 14, 2019: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $75 M offered; $50 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis W. Wahr · Executive Officer, Director Alexander A. Schmitz · Director Carolyn A. Ng · Director Christopher A. Shen · Director Henry A. Plain · Director Jonathan A. Root · Director Michael A. Carusi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dennis W. Wahr, Chief Executive Officer. Newest notice filed Feb 14, 2019. Read the notice at the SEC .
equity SEC Apr 2018 $4 M No. 5 $2 to $10 million 9
Innovative Pulmonary Solutions, Inc.: Raise no. 5, Apr 2018 × Investors in this round 9 investors had bought by the notice of May 15, 2018: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $8 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis W. Wahr · Executive Officer, Director Dave W. Stassen · Director Hank W. Plain · Director James W. Lee Tze Wei · Director Kirk W. Nielsen · Director Mark W. Deem · Director Mike W. Carusi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Excludes standard compensation for officers and directors.”Signed by Kari Kubesh, Chief Financial Officer. Newest notice filed May 15, 2018. Read the notice at the SEC .
debt, options SEC Apr 2014 $42 M No. 4 $10 to $50 million 9
Innovative Pulmonary Solutions, Inc.: Raise no. 4, Apr 2014 × Investors in this round 9 investors had bought by the notice of Apr 7, 2014: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $42 M of $42 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis Wahr · Executive Officer, Director Dave Stassen · Director Hank Plain · Director Kirk Nielsen · Director Lincoln Chee · Director Mark Deem · Director Mike Carusi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kari Kubesh, Cfo. Newest notice filed Apr 7, 2014. Read the notice at the SEC .
equity SEC Feb 2013 $10 M No. 3 $10 to $50 million 5
Innovative Pulmonary Solutions, Inc.: Raise no. 3, Feb 2013 × Investors in this round 5 investors had bought by the notice of Feb 21, 2013: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $580,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Dennis W. Wahr · Executive Officer, Director David A. Stassen · Director Henry A. Plain · Director Kirk A. Nielsen · Director Mark A. Deem · Director Michael A. Carusi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “PROCEEDS MAY BE USED FOR SALARY AND BENEFITS OF DENNIS WAHR, AS CHIEF EXECUTIVE OFFICER, AND TO REIMBURSE EXPENSES FOR THE BOARD OF DIRECTORS”Signed by Kari Kubesh, Chief Financial Officer. Newest notice filed Feb 21, 2013. Read the notice at the SEC .
equity SEC Mar 2012 $11 M No. 2 $10 to $50 million 16
Innovative Pulmonary Solutions, Inc.: Raise no. 2, Mar 2012 × Investors in this round 16 investors had bought by the notice of Apr 6, 2012: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $11 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Steven Dimmer · Executive Officer, Director David Stassen · Director Henry Plain · Director Kirk Nielsen · Director Mark Deem · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steven Dimmer, Chief Executive Offier. Newest notice filed Apr 6, 2012. Read the notice at the SEC .
equity SEC Sep 2010 $3 M No. 1 $2 to $10 million 3
Innovative Pulmonary Solutions, Inc.: Raise no. 1, Sep 2010 × Investors in this round 3 investors had bought by the notice of Sep 29, 2010: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $8 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Martin L. Mayse · Executive Officer, Director Steven Dimmer · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Steven Dimmer, Chief Executive Offier. Newest notice filed Sep 29, 2010. Read the notice at the SEC .
equity SEC